THURSDAY, OCTOBER 21, 2010
9:00 am - 12:00 pm CODING UPDATE 2010-2011
Meeting Room 552

Michael A. Ferragamo, M.D.
UroCare Associates, Garden City, New York
1:00 pm - 2:30 pm INTERACTIVE COURSE I: LAPAROSCOPY/ROBOTICS SURGICAL TECHNIQUES - Videos and Case Discussions with Experts
Ballrooms D/E
Moderators: John J. Munoz, M.D.
Steven J. Shichman, M.D.
  
V1. Robotic Assisted Laparoscopic Radical Prostatectomy Anastomotic Technique With Quill Sutures
Mehrdad Alemozaffar, M.D., Wesley Choi, M.D., Jim Hu, M.D., M.P.H.
Brigham and Women's Hospital, Boston, MA
V2. A Novel High-Fidelity Robot-Assisted Radical Prostatectomy Simulator
Mehrdad Alemozaffar, M.D.1, Ramkishen Narayanan, B.S.1, Brian Minnillo, M.D.2, Ignacio San Francisco, M.D.1, Kai Matthes, M.D.1, Hiep Nguyen, M.D.2, Andrew Wagner, M.D.1
1Beth Israel Deaconess Medical Center, Boston, MA, 2Children's Hospital Boston, Boston, MA
V3. The Posterior Approach To Transperitoneal Robotic Assisted Radical Prostatectomy: Detailed Technique
Alireza Moinzadeh, M.D., Andrea Sorcini, M.D., David Canes, M.D.
Lahey Clinic Medical Center, Burlington, MA
V4. Robot-Assisted Partial Nephrectomy: Early Unclamping Technique
Ignacio F. San Francisco, M.D.1, Michael C. Sweeney, M.D.2, Andrew A. Wagner, M.D.2
1Pontificia Universidad Católica de Chile and Beth Israel Deaconess Medical Center, Santiago, Chile, 2Beth Israel Deaconess Medical Center, Boston, MA
V5. Robotic Partial Cystectomy
Serge Ginzburg, M.D., Joseph R. Wagner, M.D.
Hartford Hospital, Hartford, CT
1:00 pm - 2:30 pm INTERACTIVE COURSE II: ERECTILE DYSFUNCTION / HYPOGONADISM / TESTOSTERONE REPLACEMENT THERAPY
Meeting Room 552
Moderators: Ricardo M. Munarriz, M.D.
Cigdem Tanrikut, M.D.

A 90 min session featuring common treatment trends in Erectile Dysfunction and Infertility. This course is designed to focus on cases that would be seen and treated by general and/or community urologists.
2:30 pm - 4:00 pm UROLOGY PRODUCT SHOWCASE: PRESENTATIONS BY INDUSTRY EXPERTS/SCIENTISTS
Ballrooms D/E
Moderators: Lori B. Lerner, M.D.
Gyan Pareek, M.D.
A 90 minute session with presentations featuring the latest information on equipment and pharmaceuticals including reports on the latest trials. This is the first session of its kind here at the New England Section and will allow the attendees to keep up-to date on the latest industry information.
4:00 pm - 5:30 pm WELCOME RECEPTION
Exhibit Hall, Ballroom A
5:30 pm - 7:00 pm YOUNG UROLOGISTS FORUM
Meeting Room 552

FRIDAY, OCTOBER 22, 2010
7:30 am CONTINENTAL BREAKFAST, VISIT EXHIBITS
Exhibit Hall, Ballroom A
8:00 am - 8:20 am INTRODUCTION & WELCOME
Ballrooms D/E
Mark Sigman, M.D., President
New England Section of the American Urological Association

Sushil S. Lacy, M.D., President Elect
American Urological Association

Stephen Schiff, M.D., Local Arrangements
8:20 am - 10:30 am SCIENTIFIC SESSION I: PROSTATE CANCER
Ballrooms D/E
Moderators: Joseph F. Renzulli, M.D.
Peter C. Albertsen, M.D.
8:20 am *1. Population-Based Determinants of Radical Prostatectomy Surgical Margin Positivity and Identifying Underperforming Surgeons
Stephen B. Williams, M.D., Xiangmei Gu, M.S., Stuart Lipsitz, PhD., Anthony D'Amico, M.D., Ph.D., Jim Hu, M.D., MPH
Brigham and Women's Hospital, Boston, MA
8:30 am 2. Updated Survival Results of the IMPACT Trial of Sipuleucel-T for Metastatic Castration-Resistant Prostate Cancer
E. Roy Berger, M.D.1, Philip W. Kantoff, M.D.2, Celestia S. Higano, M.D.3, Neal D. Shore, M.D.4, Eric J. Small, M.D.5, David F. Penson, M.D.6, Robert B. Sims, M.D.7, Yi Xu, PhD7, Mark W. Frohlich, M.D7, Paul F. Schellhammer, M.D.8
1SUNY School of Medicine, Stony Brook, NY, 2Harvard Medical School, Boston, MA, 3University of Washington, Seattle, WA, 4Grand Strand Urology, Myrtle Beach, SC, 5UCSF Urologic Oncology Program, San Francisco, CA, 6Vanderbilt University Medical Center, Nashville, TN, 7Dendreon Corporation, Seattle, WA, 8Eastern Virginia Medical School, Norfolk, VA
8:40 am 3. Toremifene 80 mg Demonstrates Reduction in Fracture Risk in Men Who Are Less Than 80 Years of Age on Androgen Deprivation Therapy
Robert Feldman, M.D.1, Michael Flanagan, M.D. 1, Michael Brawer, M.D.2
1Connecticut Clinical Research, Middlebury, CT, 2GTx, Inc, Memphis, TN
8:50 am 4. A Phase 3 Randomized Trial of Denosumab Versus Zoledronic Acid In Patients With Bone Metastases From Castration-Resistant Prostate Cancer
Lawrence Karsh, M.D. 1, Matthew Smith, M.D., PhD2, Neal Shore, M.D., FACS3, Karim Fizazi, M.D., PhD4, Michael Carducci, M.D. 5, Ronaldo Damião, M.D., PhD6, Janet Brown, M.D. 7, Piotr Milecki, M.D., PhD8, Huei Wang, PhD9, Roger Dansey, M.D. 9, Carsten Goessl, M.D. 9
1The Urology Center of Colorado, Denver, CO, 2Massachusetts General Hospital Cancer Center, Boston, MA, 3Carolina Urological Research Center, Myrtle Beach, SC, 4Institut Gustave Roussy, University of Paris, Villejuif, France, 5Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 6Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil, 7Cancer Research UK Clinical Centre, Leeds, United Kingdom, 8Wielkopolskie Centrum Onkologii, Poznan, Poland, 9Amgen Inc., Thousand Oaks, CA
9:00 am 5. Presentation of Patients with Metastatic Prostate Cancer in the Post-PSA Era
Rian J. Dickstein, M.D., Jamal A. Nabhani, B.S., Jessica E. Kreshover, M.D., Richard K. Babayan, M.D., Mark H. Katz, M.D., Gretchen A. Gignac, M.D.
Boston University School of Medicine, Boston, MA
9:10 am *6. Neoadjuvant Chemotherapy Followed by Radical Prostatectomy in Patients with Intermediate to High Risk Prostate Cancer
Mehrdad Alemozaffar, M.D. 1, Stephen B. Williams, M.D. 1, Xiangmei Gu, Ph.D. 2, Nathanael Hevelone, 2, Stuart R. Lipsitz, Ph.D.2, William K. Oh, M.D. 3, Tiffany Lin, B.S. 3, Aaron C. Weinberg, M.D. 1, Peter Chang, M.D. 1, Toni K. Choueiri, M.D. 4, Glenn Bubley, M.D. 4, WIlliam DeWolf, M.D.4, Jerome P. Richie, M.D. 1, Jim C.Hu, M.D., M.P.H. 1.
1Division of Urologic Surgery, Brigham and Women's Hospital, Boston, MA, USA, 2Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA,USA, 3Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA, 4Cancer Center, Beth Isreal Deaconess Medical Center
9:20 am 7. Utilization of Secondary Cancer Treatments Following Radical Prostatectomy
Stephen B. Williams, M.D., Xiangmei Gu, M.S., Stuart R. Lipsitz, Ph.D., Jim C. Hu, M.D., MPH
Brigham and Women's Hospital, Boston, MA
9:30 am *8. Perineal Radical Prostatectomy: Back to the Future?
Sandip M. Prasad, M.D.3, M. Phil. 1, Xiangmei Gu, M.S. 2, Rebecca S. Lavelle, M.D.1, Stuart R. Lipsitz, Sc.D. 2, Jim C. Hu, M.D., M.P.H.3
1Harvard-Longwood Program in Urology, Boston, MA, 2Center for Surgery and Public Health, Brigham and Women’s Hospital, Boston, MA, 3Brigham and Women's Hospital, Boston, MA
9:40 am *9. Comparative Complications of Cryotherapy vs. Brachytherapy in Men With Localized Prostate Cancer
Stephen B. Williams, M.D., Yin Lei, M.D., Stuart R. Lipsitz, Ph.D., Anthony V. D’Amico, M.D., PhD., Jim C. Hu, M.D., MPH
Brigham and Women's Hospital, Boston, MA
9:50 am 10. The Impact of Co-Morbidity on Life Expectancy Among Men With Newly Diagnosed Prostate Cancer
Peter C. Albertsen, M.D.1, Dirk F. Moore, PhD2, Weichung Shih, PhD2, Yong Lin, PhD2, Hui Li, PhD3, Grace Lu-Yao, PhD4
1University of Connecticut, Farmington, CT, 2University of Medicine and Dentistry, Piscataway, NJ, 3Cancer Institute of New Jersey, New Brunswick, NJ, 4Robert Wood Johnson Medical School, New Brunswick, NJ
10:00 am - 10:20 am POINT/COUNTERPOINT
Moderator: Peter C. Albertsen, M.D.
Panelists: Jim C. Hu, M.D.
Martin G. Sanda, M.D.
10:20 am - 10:30 am PROSTATE CANCER: TAKE HOME MESSAGES FROM SAN FRANCISCO TO PROVIDENCE
Moderator: Mark H. Katz, M.D.
10:30 am - 11:00 am COFFEE BREAK, VISIT EXHIBITS
11:00 am - 1:10 pm SCIENTIFIC SESSION II: KIDNEY/BLADDER CANCER
Ballrooms D/E
Moderators: Jason R. Gee, M.D.
Francis J. McGovern, M.D.
11:00 am 11. Percutaneous Renal Cryoablation: A Single Institutional Experience
Sutchin R. Patel, M.D., Meghan G. Lubner, M.D., James L. Hinshaw, M.D., Christopher L. Brace, M.D., Sean P. Hedican, M.D., Fred T. Lee, M.D., Stephen Y. Nakada, M.D.
University of Wisconsin School of Medicine and Public Health, Madison, WI
11:10 am 12. Salvage Radiofrequency Ablation Achieves Effective Local Control of Recurrent Renal Cell Carcinoma
Sarah P. Psutka, M.D., Ali Daha, BA, Debra Gervais, M.D., Adam S. Feldman, M.D.
Massachusetts General Hospital, Boston, MA
11:20 am 13. Radiofrequency Ablation of Centrally Located Renal Tumors is Associated with Increased Rates of Major Complications
Sarah P. Psutka, M.D., Ali Daha, BA, Debra Gervais, M.D., Adam S. Feldman, M.D.
Massachusetts General Hospital, Boston, MA
11:30 am 14. The Economic Evaluation of Chronic Kidney Disease in the Outcomes for Radical versus Partial Nephrectomy in the Management of Small Renal Masses
Steven L. Chang, M.D.1, Lauren E. Cipriano, MS2, Lauren C. Harshman, M.D. 2, Alan M. Garber, M.D. PhD2, Benjamin I. Chung, M.D. 2
1Brigham and Women's Hospital, Boston, MA, 2Stanford University, Stanford, CA
11:40 am 15. Comparison of Hilar Clamping and Non-Hilar Clamping Partial Nephrectomy for Tumors Involving a Solitary Kidney
Matthew F. Wszolek, M.D.1, Patrick A. Kenney, M.D. 1, Yoojin Lee, MPH2, John A. Libertino, M.D. 1
1Lahey Clinic, Burlington, MA, 2Tufts Medical Center, Boston, MA
11:50 am *16. Private VS. Public Insurance: Is There A Difference In Survival In Patients With Bladder Urothelial Carcinoma?
Mohummad M. Siddiqui, M.D., Niall M. Heney, M.D., W. Scott McDougal, M.D., Adam S. Feldman, M.D., MPH
Massachusetts General Hospital, Boston, MA
12:00 am 17. Complications After Radical Cystectomy According To The Clavien System And Their Impact On Survival - A Single Center Experience
Marc D. Manganiello, M.D., John A. Libertino, M.D., Andrea Sorcini, M.D., Karim J. Hamawy, M.D., Ali Moinzadeh, M.D., David Canes, M.D., Jason R. Gee, M.D.
Lahey Clinic Medical Center, Burlington, MA
12:10 am 18. Robotic Radical Cystectomy
Cory Harris, M.D., Serge Ginzburg, M.D., Joseph R. Wagner, M.D.
Hartford Hospital, Hartford, CT
12:20 am 19. Comparison of Radical Cystectomy in Patients with and without Prior Pelvic Irradiation
Spencer I. Kozinn, M.D.1, Niall J. Harty, M.D. 1, Jessica M. DeLong, M.D. 1, Yoojin Lee, MS, MPH2, Karim Hamawy, M.D. 1, David Canes, M.D. 1, Jason Gee, M.D. 1, John A. Libertino, M.D. 1, Andrea Sorcini, M.D. 1, Alireza Moinzadeh, M.D. 1
1Lahey Clinic Medical Center, Burlington, MA, 2Tufts Medical Center, Boston, MA
12:30 am 20. Neoadjuvant Dose-Dense Methotrexate, Vincristine, Adriamycin, Cisplatin (dd-MVAC) in Patients With Muscle Invasive Bladder Cancer
Stephen B. Williams, M.D., Anne K. Mongiu, M.D., Ph.D., Fabio A. Schutz, M.D., Michelle S. Hirsch, M.D., Ph.D., Nikhil H. Ramaiya, M.B.B.S., Graeme S. Steele, M.D., Jim C. Hu, M.D., M.P.H., Toni K. Choueiri, M.D., Jonathan E. Rosenberg, M.D.
Brigham and Women's Hospital, Boston, MA
12:40 pm - 1:00 pm POINT/COUNTERPOINT
Moderator: Francis J. McGovern, M.D.
Panelists: John W. Colberg, M.D.
Jason R. Gee, M.D.
1:00 pm - 1:10 pm KIDNEY/BLADDER CANCER: TAKE HOME MESSAGES FROM SAN FRANCISCO TO PROVIDENCE
Joseph R. Wagner, M.D.
1:10 pm - 2:15 pm LUNCH SYMPOSIUM
Ballrooms D/E
PROVENGE® (sipuleucel-T) in Advanced Prostate Cancer
Supported by Dendreon
1:10 pm - 2:15 pm LUNCH SYMPOSIUM
Meeting Room 552
Recent Discoveries in Prostate Cancer: The Role of the RANK Ligand Pathway
Supported by Amgen
2:15 pm - 3:55 pm CONCURRENT SCIENTIFIC SESSION III: GENERAL UROLOGY/MISCELLANEOUS
Ballrooms D/E
Moderators: Robert D. Blute, M.D.
Stanton C. Honig, M.D.
2:15 pm 21. Reduced Levels of 5-? Reductase 2 in Adult Prostate Tissue and Implications for BPH Therapy
Yinong Niu, M.D., PhD., Christian Diaz, M.D., Rongbin Ge, M.D., PhD., Zongwei Wang, M.D., PhD., Chin-Lee Wu, M.D., PhD., Aria F. Olumi, M.D.
Massachusetts General Hospital, Boston, MA
2:25 pm 22. Effect of Prostate Volume on Silodosin-Mediated Improvement of Symptoms Associated With Benign Prostatic Hyperplasia
Steven A. Kaplan, M.D. 1, Claus Roehrborn, M.D.2, Lawrence Hill, Phar, M.D.3, Weining Volinn, MS3, Gary E. Hoel, PhD3
1Weill Cornell Medical College, New York, NY, 2UT Southwestern Medical Center, Dallas, TX, 3Watson Laboratories, Inc., Salt Lake City, UT
2:35 pm 23. Nocturnal Polyuria Is Frequently Found In Patients With Nocturia Irrespective Of Co-Existing Lower Urinary Tract Symptoms
Bjarke M. Klein, PhD1, Jeffrey P. Weiss, M.D.2, Brian Marks M.D.2
1Ferring International Pharmascience Center, Copenhagen, Denmark, 2SUNY Downstate Medical School, Brooklyn, NY
2:45 pm 24. Effect of the Severity of Incontinence on the Efficacy of Oxybutynin Chloride Topical Gel (OTG) in Improving Continence
Peter K. Sand, M.D.1, Scott A. MacDiarmid, M.D.2, Heather Thomas, PhD3, Kim E. Caramelli, MS3, Gary Hoel, PhD3
1University of Chicago, Pritzker School of Medicine, Chicago, IL, 2Alliance Urology Specialists, Greensboro, NC, 3Watson Laboratories, Inc., Salt Lake City, UT
2:55 pm 25. Do the Effects of Oxybutynin on Cognition Depend on the Route of Administration Topical or Oral? Results of a Double-Blind Placebo-Controlled Study in Healthy, Older Adults
Gary G. Kay, PhD1, David R. Staskin, M.D.2, Scott MacDiarmid, M.D.3, Marilyn McIlwain, MS4, Naomi V. Dahl, Phar M.D. 4
1Cognitive Research Corporation, St. Petersburg, FL, 2Tufts University Medical Center, Boston, MA, 3Alliance Urology Specialists, Greensboro, NC, 4Watson Laboratories, Inc., Morristown, NJ
3:05 pm 26. Management of Complex Anterior Urethral Strictures With Multi-Stage Buccal Graft Urethroplasty
Spencer I. Kozinn, M.D., Niall J. Harty, M.D., Alex Vanni, M.D., Leonard Zinman, M.D., Jill Buckley, M.D.
Lahey Clinic Medical Center, Burlington, MA
3:15 pm 27. Hand Assisted Retroperitoneoscopic Live Donor Nephrectomy: Operative Technique And Clinical Outcomes. The Largest Single Institution Experience of 200 Consecutive Cases
Satya Allaparthi, MRCS,M.D., Sayeed Malek, M.D., Stefan Tullius, M.D.,PhD, Sanjaya Kumar, M.D.
Brigham and Women’s Hospital, Boston, MA
3:25 pm 28. Cost Effective Office Based Loupe Magnification Microscopic Epididymal Sperm Aspiration (MESA) with Local Anesthesia Only: Is it Safe andEfficacious?
Guy J. Manetti, M.D.1, Stanton C. Honig, M.D.2
1Yale New Haven Hospital, New Haven, CT, 2The Urology Center, New Haven, CT
3:35 pm 29. Updated Analysis of Training Attempts In Men Using Intracavernosal Injection Therapy After Radical Prostatectomy
Cara Cimmino, M.D., Nelson Bennett, Jr., M.D.
Lahey Clinic Medical Center, Burlington, MA
3:45 pm 30. Assessment of EndoPat Scores in Men with Vasculogenic and Non-Vasculogenic Erectile Dysfunction
Akanksha Mehta, M.D., Martin Miner, M.D., Mark Sigman, M.D.
Warren-Alpert School of Medicine at Brown University, Providence, RI
3:55 pm - 4:05 pm UPDATE ON THE AUA'S MEN'S HEALTH COMMITTEE
Kevin L. Loughlin, M.D.
2:15 pm – 4:05 pm CONCURRENT POSTER SESSION I: BASIC SCIENCE
Rotunda
Moderators: Mary Rose Sullivan, M.D.
Katarina Zvarova, M.D.
2:15 pm VIEWING
2:45 pm P1. Microvesicle Induction of Prostate Specific Gene Expression in Normal Human Bone Marrow Cells
Michael Del Tatto, BS1, Joseph F. Renzulli, III, M.D.2, Gerri Dooner, BS1, Lisa Goldstein, M.D. 2, Mark Dooner, BS1, Gerald Colvin, DO1, Devasis Chatterjee, Ph.D. 1, Peter J. Quesenberry, M.D. 1
1Rhode Island Hospital, Providence, RI, 2The Miriam Hospital, Providence, RI
2:53 pm P2. Genome-Wide Microarray Analysis of Semen RNAs from Men With Biopy-Proven Prostate Cancer or Benign Hyperplasia
Robert C. Eyre, M.D. 1, Brian Desmarais, B.S. 2, HZ Yin, M.D. 2, Ann A. Kiessling, PhD1
1Bedford Research Foundation, Beth Israel Deaconess Medical Center, Somerville and Boston, MA, 2Bedford Research Foundation, Somerville, MA
3:01 pm P3. Detection and Identification of miRNA in Cell-Free Urine: Potential Utility in Bladder Cancer
Jessica DeLong, M.D., Niall Harty, M.D., Spencer Kozinn, M.D., Kimberly Rieger-Christ, PhD, Kelly Summerhayes, BS, John Libertino, M.D., Ian Summerhayes, PhD
The Lahey Clinic, Burlington, MA
3:09 pm P4. MicroRNA Expression Linked To Gemcitabine Resistance in an in Vitro Bladder Carcinoma Model
Spencer I. Kozinn, M.D., Niall J. Harty, M.D., Jessica M. DeLong, M.D., Kimberly M. Rieger-Christ, PhD, John A. Libertino, M.D., Ian C. Summerhayes, PhD
Lahey Clinic Medical Center, Burlington, MA
3:17 pm P5. ALDH1 Expression in Bladder Cancer Correlates with Histopathologic Indicators of Poor Prognosis
Sammy E. Elsamra, M.D., Andres Matoso, M.D., Kamaljeet Singh, M.D., Rosemarie Tavares, B.S., Lelia Noble, B.S., Joseph Renzulli, M.D., George Haleblian, M.D., Murray B. Resnick, M.D., Li J. Wang, M.D., Gyan Pareek, M.D.
Warren Alpert Medical School of Brown University, Providence, RI
3:25 pm P6. Inflammatory and Apoptotic Mediators are Increased in the Bladder in a Type 2 Diabetic Genetic Model
Zongwei Wang, M.D., PhD1, Zhiyong Cheng, M.D., PhD2, Vivian Cristofaro, PhD3, Edward Gong, M.D. 2, Maryrose Sullivan, PhD3, Rosalyn Adam, PhD2, Morris White, PhD2, Aria F. Olumi, M.D.1
1Massachusetts General Hospital, Boston, MA, 2Children's Hospital, Boston, MA, 3VA Boston Healthcare System, Boston, MA
3:33 pm P7. F-Box Protein 10, a NF-KB-Dependent Anti-Apoptotic Protein, Regulates TRAIL-Induced Apoptosis Through Activation of C-Fos and Repression of C-FLIP
Rongbin Ge, M.D., PhD1, Zongwei Wang, M.D., PhD1, Qing Zheng, PhD2, Xiaoyin Xu, PhD2, Aria F. Olumi, M.D.1
1Massachusetts General Hospital, Boston, MA, 2Brigham & Women's Hospital, Boston, MA
3:41 pm P8. MiRNA Profiles In Bladder Carcinoma Cells Linked To Epithelial-Mesenchymal Transition (EMT) And Different Biomarker Proteins In Bladder Cancer
Niall J. Harty, M.D., Spencer I. Kozinn, M.D., Jessica M. DeLong, M.D., Christina S. Deliyiannis, BS, Kimberly M. Reiger-Christ, PhD, Jason Gee, M.D., John A. Libertino, M.D., Ian C. Summerhayes, PhD
Lahey Clinic, Burlington, MA
3:49 pm  P9. WITHDRAWN
3:57 pm  P10. WITHDRAWN
4:05 pm - 4:45 pm INVITED SPEAKER
Ballrooms D/E
Androgen Replacement – The Truth About the Risks
Andre T. Guay, M.D.
Peabody, MA
4:45 pm ADJOURN
4:45 pm - 6:00 pm ATTENDEE RECEPTION
Exhibit Hall, Ballroom A
SATURDAY, OCTOBER 23, 2010
7:00 am CONTINENTAL BREAKFAST, VISIT EXHIBITS
Exhibit Hall, Ballroom A
7:30 am - 8:00 am BUSINESS MEETING
Ballrooms D/E
8:00 am - 10:00 am CONCURRENT SCIENTIFIC SESSION IV: FEMALE UROLOGY/INCONTINENCE
Meeting Room 552
Moderators: Richard T. Kershen, M.D.
David Staskin, M.D.
8:00 am 31. Effect of Voluntary Dose Escalation on Placebo Effects in a Trial of Antimuscarinic Treatment for Overactive Bladder
David R. Staskin, M.D.1, Martin C. Michel, PhD2
1Tufts University School of Medicine, Boston, MA, 2University of Amsterdam, Amsterdam, Netherlands.
8:10 am *32. Caffeine Intake And Risk Of Stress, Urgency, And Mixed Urinary Incontinence
Ying H. Jura, M.D.1, Mary K. Townsend, ScD2, Francine Grodstein, ScD3
1Massachusetts General Hospital, Boston, MA, 2Harvard School of Public Health, Boston, MA, 3 Brigham and Women's Hospital, Boston, MA
8:20 am *33. Outcomes and Morbidity for Multiple Sclerosis Patients Undergoing Urinary Diversion/Reconstruction
Jessica DeLong, M.D.1, John Stoffel, M.D. 1, Hocine Tighiouart, MS2
1The Lahey Clinic, Burlington, MA, 2Tufts University Medical Center, Boston, MA
8:30 am 34. Efficacy of Neuromodulation for Refractory Interstitial Cystitis/Painful Bladder Syndrome
Sara M. Lenherr, M.D., Gjanje L. Smith, M.D., John F. Bresette, M.D., John T. Stoffel, M.D.
Lahey Clinic Medical Center, Burlington, MA
8:40 am 35. Two-Year Follow-up Results in a Multi-Center, Prospective Trial of the AdVance® Male Sling System for the Treatment of Post-Prostatectomy Stress Urinary Incontinence
Michael J. Kennelly, M.D.1, Kurt A. McCammon, M.D.2, L. Dean Knoll, M.D.3, LeRoy A. Jones, M.D.4, Gregory T. Bales, M.D.5, Sender Herschorn, M.D., FRCSC6, Brian Roberts, M.D.7, Timothy B. Boone, M.D., PhD8, George D. Webster, M.D.9
1Carolinas Medical Center, Charlotte, NC, 2Eastern Virginia Medical School, Norfolk, VA, 3Center for Urological Treatment and Research, Nashville, TN, 4Urology San Antonio Research, PA, San Antonio, TX, 5University of Chicago Medical Center, Chicago, IL, 6University of Toronto, Toronto, ON, Canada, 7Carolina Urologic Research Center, Myrtle Beach, SC, 8The Methodist Hospital, Houston, TX, 9Duke University, Durham, NC
8:50 am 36. The AdVance Transobturator Male Sling for Postprostatectomy Incontinence: Clinical Results of a Prospective Evaluation Utilizing Patient-Driven Questionnaires
Justin Gould, M.D., John Stoffel, M.D., Arthur Mourtzinos, M.D.
Lahey Clinic Medical Center, Burlington, MA
9:00 am 37. Patient-Reported Outcomes of a Single-Surgeon's Experience with the Advance Male Sling
Anne M. Suskind, M.D.1, Bruce Bernstein, PhD1, Marlene Murhpy-Setzko, M.D.2
1University of Connecticut, Farmington, CT, 2St Francis Hospital, Hartford, CT
9:10 am 38. Correlation Between Quality Of Life And Voiding Variables In Patients With Refractory Overactive Bladder Syndrome Treated With Percutaneous Tibial Nerve Stimulation
Marybeth Singh, NP, John F. Bresette, M.D., John T. Stoffel, M.D., Arthur Mourtzinos, M.D.
Lahey Clinic Medical Center, Burlington, MA
9:20 am - 9:50 am CONCURRENT POINT/COUNTERPOINT
Moderator: David Staskin, M.D.
Panelists: Paula B. Bellin, M.D.
Richard T. Kershen, M.D.
9:50 am - 10:00 am FEMALE UROLOGY/INCONTINENCE: TAKE HOME MESSAGES FROM SAN FRANCISCO TO PROVIDENCE
Anurag K. Das, M.D.
8:00 am – 10:10 am CONCURRENT SCIENTIFIC SESSION V: LAPAROSCOPY/ROBOTICS PODIUM
Ballrooms D/E
Moderators: Douglas M. Dahl, M.D.
Dinesh Singh, M.D.
8:00 am 39. Comparison of Surgical Outcomes for Laparoscopic Versus Robotic Partial Nephrectomy in 200 patients: A Single Surgeon Experience
Kyle T. Finnegan, BS1, Anoop M. Meraney, M.D. 1, Lei Wang, M.D.2, Stuart S. Kesler, M.D.1, Steven J. Shichman, M.D.1
1Hartford Hospital, Hartford, CT, 2Qilu Hospital of Shandong University, Jinan, China
8:10 am 40. A Single Surgeon’s First 150 Robotic Partial Nephrectomy Cases: Analysis of the Learning Curve
Kyle T. Finnegan, BS1, Anoop M. Meraney, M.D. 1, Anne M. Suskind, M.D.2, Stuart S. Kesler, M.D. 1, Steven J. Shichman, M.D. 1
1Hartford Hospital, Hartford, CT, 2University of Connecticut, Farmington, CT
8:20 am 41. Oncologic Efficacy of Laparoscopic and Robotic Partial Nephrectomy Compared to Open Partial Nephrectomy for Renal Tumors ? T1b
Kyle T. Finnegan, BS, Steven J. Shichman, M.D., Joseph R. Wagner, M.D., Stuart S. Kesler, M.D., Anoop M. Meraney, M.D.
Hartford Hospital, Hartford, CT
8:30 am 42. Temporary Targeted Blood Flow Interruption using a Reverse Thermosensitive Polymer to Facilitate Bloodless Partial Nephrectomy
Niall J. Harty, M.D.1, Jessica M. DeLong, M.D. 1, Spencer I. Kozinn, M.D. 1, Alireza Moinzadeh, M.D. 1, Sebastian Flacke, M.D. 1, Jim Benn, PhD2, John A. Libertino, M.D. 1, Peter N. Madras, M.D. 2
1Lahey Clinic, Burlington, MA, 2Pluromed Inc, Woburn, MA
8:40 am 43. The Effect of Bilateral, Unilateral, and Non-Nerve Sparing Robot-Assisted Laparoscopic Prostatectomy on Quality of Life Outcomes
David Chalmers, M.D.1, Ilene Staff, Ph.D. 2, Steven Shichman, M.D. 2, Joseph R. Wagner, M.D. 2, Stuart Kesler, M.D. 2
1University of Connecticut Health Center, Farmington, CT, 2Hartford Hospital, Hartford, CT
8:50 am 44. Comparative Evaluation of Concomitant Lymphadenectomy in Robot-Assisted Radical Prostatectomy: Extraperitoneal Versus Transperitoneal Approach Preliminary Analysis of Outcomes
Satya Allaparthi, MRCS,M.D., Thomas Hoang, M.D., Nadeem N. Dhanani, M.D., MPH, Ingolf A. Tuerk, M.D.,PhD
Caritas St Elizabeth Hospital, Boston, MA
9:00 am 45. Perioperative Complications of Robot Assisted Laparoscopic Radical Prostatectomy: The Initial 476 Cases of the Brown University Experience
Michael S. Lasser, M.D., Joseph Renzulli, M.D., George E. Haleblian, M.D., Gyan Pareek, M.D.
Brown University, Providence, RI
9:10 am 46. Extraperitoneal Versus Transperitoneal Approach to Robotic Assisted Radical Prostatectomy: Comparative Analysis of Surgical Technique and Operative Outcomes-Single Institution Experience
Satya Allaparthi, MRCS,M.D., Thomas Hoang, M.D., Nadeem N. Dhanani, M.D., MPH, Ingolf A. Tuerk, M.D.,PhD
Caritas St Elizabeth Hospital, Boston, MA
9:20 am 47. Significance of Prostate Weight on Peri and Post Operative Outcomes of Robot-Assisted Laparoscopic Extra Peritoneal Prostatectomy
Satya Allaparthi, MRCS, M.D., Thomas Hoang, M.D., Nadeem N. Dhanani, M.D., MPH,Ingolf A. Tuerk, M.D.,PhD
Caritas St Elizabeth Hospital, Boston, MA
9:30 am 48. Incidence of Deep Venous Thrombosis and Lymphoceles After Robotic Assisted Laparoscopic Radical Prostatectomy and Concomitant Pelvic Lymphadenectomy. Does Pharmacological Prophylaxis Matter?
Jessica Kreshover, M.D., Satya Allaparthi, MRCS, M.D., Thomas Hoang, M.D., Nadeem N. Dhanani, M.D., MPH, Ingolf A. Tuerk, M.D.,PhD
Caritas St Elizabeth Hospital, Boston, MA
9:40 am - 10:00 am CONCURRENT POINT/COUNTERPOINT
Moderator: Douglas M. Dahl, M.D.
Panelists: Alireza Moinzadeh, M.D.
Dinesh Singh, M.D.
10:00 am - 10:10 am LAPAROSCOPY /ROBOTICS: TAKE HOME MESSAGES FROM SAN FRANCISCO TO PROVIDENCE
Joshua M. Stern, M.D.
10:10 am - 10:40 am COFFEE BREAK, VISIT EXHIBITS
10:40 am - 12:50 pm CONCURRENT SCIENTIFIC SESSION VI: PEDIATRICS
Ballrooms D/E
Moderators: Marc Cendron, M.D.
Pamela I. Ellsworth, M.D.
10:40 am 49. Long-term Follow-up of Primary Obstructive Megaureter
Liza M. Aguiar, M.D.1, Dacia Di Renzo, M.D. 2, Pamela I. Ellsworth, M.D.1, Pierluigi Lelli Chiesa, M.D. 2, Anthony A. Caldamone, M.D.1
1Pediatric Urology, Brown University and Hasbro Children's Hospital, Providence, RI, 2Pediatric Surgery, D'Annunzio University and Spirito Santo Hospital, Chieti-Pescara, Italy
10:50 am 50. Gender Assignment for 46XY Cloacal Exstrophy: AAP Urology Section Survey
David A. Diamond, M.D., Jeffrey P. Burns, M.D., Ilina Rosoklija, MPH, Lin Huang, PhD, Alan B. Retik, M.D.
Children's Hospital, Boston, MA
11:00 am 51. Renal Damage Risk Assessment in Vesicoureteral Reflux: A Pilot Study
Akanksha Mehta, M.D., Jason T. Machan, Ph.D., Anthony A. Caldamone, M.D.
Warren-Alpert School of Medicine at Brown University, Providence, RI
11:10 am 52. A Novel Method of Identifying Ureteropelvic Junction Obstruction: A Comparative Study of Imaging Modalities in Assessing Renal Function and Degree of Obstruction in a Swine Model
Courtney K. Rowe, M.D., Brian J. Minnillo, M.D., Young K. Hong, M.D., Alan B. Retik, M.D., Hiep T. Nguyen, M.D.
Children's Hospital Boston, Boston, MA
11:20 am 53. Left Subclinical Varicoceles Are Associated with Clinical Progression
Richard N. Yu, M.D., Ph.D., Harriet J. Paltiel, M.D., David A. Diamond, M.D.
Children's Hospital Boston, Boston, MA
11:30 am 54. Hyperbaric Oxygen as Adjuvant Therapy after Failed Hypospadias Repair
Christina Kim, M.D., Susan Marai, R.N., Fernando A. Ferrer, Jr., M.D.
Connecticut Children's Medical Center, Hartford, CT
11:40 am 55. A Comparison Study of Robotic-Assisted Laparoscopic vs. Open Ureteral Reimplantation for Treatment of Vesicoureteral Reflux in Children and Young Adults
Courtney K. Rowe, M.D., Brian J. Minnillo, M.D., Young K. Hong, M.D., David A. Diamond, M.D., Alan B. Retik, M.D., Hiep T. Nguyen, M.D.
Children's Hospital Boston, Boston, MA
11:50 am 56. A Nine-Year experience on Robotic-Assisted Laparoscopic Pyeloplasty for Children and Young Adults
Courtney K. Rowe, M.D., Brian J. Minnillo, M.D., Jose Cruz, M.D., Rogerio H. Sayao, M.D., Alan B. Retik, M.D., Hiep T. Nguyen, M.D.
Children's Hospital Boston, Boston, MA
12:00 am 57. A Comparative Cost Analysis of Pediatric Urological Robotic-Assisted Laparoscopic Surgery vs. Open Surgery
Lisa V. Ferreira, BSPS, Brian J. Minnillo, M.D., Fernando A. Carvas, M.D. Katherine Tecci, MBA, Courtney K. Rowe, M.D., Alan B. Retik, M.D., Hiep T. Nguyen, M.D.
Children's Hospital Boston, Boston, MA
12:10 am 58. Assessing Voiding Function after Robotic-Assisted Laparoscopic Extravesical Ureteral Reimplantation
David Chalmers, M.D.1, Katherine Herbst, M.Sc.2, Christina Kim, M.D. 2
1University of Connecticut Medical Center/Connecticut Children's Medical Center, Hartford, CT, 2Connecticut Children's Medical Center, Hartford, CT
12:20 pm - 12:40 pm POINT/COUNTERPOINT
Moderator: Marc Cendron, M.D.
Panelists: Pamela I. Ellsworth, M.D.
Brian M. Jumper, M.D.
12:40 pm - 12:50 pm PEDIATRICS: TAKE HOME MESSAGES FROM SAN FRANCISCO TO PROVIDENCE
Daniel Brandon Herz, M.D.
10:40 am - 12:14 pm CONCURRENT POSTER SESSION II: LAPAROSCOPY/ROBOTICS
Rotunda
Moderators: George E. Haleblian, M.D.
Samuel J. Trotter, M.D.
10:40 am VIEWING
11:10 am P11. A Novel Scoring System for Rating the Complexity of Renal Tumors
Lei Wang, M.D.1, Kyle T. Finnegan, BS2, Anoop M. Meraney, M.D. 2, Stuart S. Kesler, M.D. 2, Steven J. Shichman, M.D. 2
1Qilu Hospital of Shandong University, Jinan, China, 2Hartford Hospital, Hartford, CT
11:18 am P12. Laparoscopic Radical Nephrectomy for T3 and Metastatic Renal Cell Carcinoma
Ignacio F. San Francisco, M.D. 1, Mehrdad Alemozaffar, M.D.2, Oseas Neves, M.D. 2, Jodi Mechaber, NP2, Andrew A. Wagner, M.D. 2
1Pontificia Universidad Católica de Chile and Beth Israel Deaconess Medical Center, Santiago, Chile, 2Beth Israel Deaconess Medical Center, Boston, MA
11:26 am P13. A Modified Technique for Trocar Placement in Robotic Partial Nephrectomy to Reduce Collision of the 3rd and 4th Robotic Arms
Kyle T. Finnegan, BS, Anoop M. Meraney, M.D., Stuart S. Kesler, M.D., Steven J. Shichman, M.D.
Hartford Hospital, Hartford, CT
11:34 am P14. Does Obesity Affect Intraoperative, Pathological Outcomes and Approach Chosen In Patients Undergoing Robot-Assisted Radical Prostatectomy (RARP)? Comparative Analysis of Extra-Peritoneal Vs Trans- Peritoneal Approaches - A Single Institution Experience
Jessica Kreshover, M.D., Satya Allaparthi, MRCS,M.D., Thomas Hoang, M.D., Nadeem N. Dhanani, M.D., MPH, Ingolf A. Tuerk, M.D.,PhD
Caritas St Elizabeth Hospital, Boston, MA
11:42 am P15. Lymph Node Yields With Pelvic Lymphadenectomy During Robotic-Assisted Laparoscopic Radical Prostatectomy - Extra Peritoneal (EP) Vs Transperitoneal (TP) Does The Approach Matter?
Satya Allaparthi, MRCS,M.D., Thomas Hoang, M.D., Nadeem N. Dhanani, M.D., MPH, Ingolf A. Tuerk, M.D.,PhD
Caritas St Elizabeth Hospital, Boston, MA
11:50 am P16. The Incidence And Contemporary Management Of Symptomatic Lymphoceles After Robotic-Assisted Extraperitoneal Laparoscopic Radical Prostatectomy And Pelvic Lymph Node Dissection
Thomas Hoang, M.D., Satya Allaparthi, MRCS,M.D., Ingolf A. Tuerk, M.D.,PhD
Caritas St. Elizabeth Hospital, Boston, MA
11:58 am P17. Margin Status Predicts Biochemical Recurrence
Thomas Nevers, BA1, Serge Ginzburg, M.D.2, Ilene Staff, PhD1, Jamie Fisch, BA1, Alison Champagne, BA1, Joseph Tortola, BS1, Stuart S. Kesler, M.D. 1, Joseph R. Wagner, M.D.1
1Hartford Hospital, Hartford, CT, 2University of Connecticut, Farmington, CT
12:06 pm P18. Complications And Conversions Of Upper Tract Urologic Laparoendoscopic Single-Site Surgery (Less): Multi-Center Experience Results from the NOTES Working Group
Brian H. Irwin, M.D.1, Jeffrey A. Cadeddu, M.D.2, Chad R. Tracy, M.D. 2, Fernando J. Kim, M.D.3, Wilson R. Molina, M.D.3, Abhay Rane, M.D.4, Chandru P. Sundaram, M.D.5, James H. Raybourne, III, M.D.5, Robert J. Stein, M.D.6, Inderbir S. Gill, M.D.7, Louis R. Kavoussi, M.D.8, Lee Richstone, M.D.8, Mihir M. Desai, M.D.7
1University of Vermont College of Medicine, Burlington, VT, 2University of Texas Southwestern Medical Center, Dallas, TX, 3Tony Grampsas Cancer Center, University of Colorado Health Sciences Center, Denver, CO, 4East Surrey Hospital, East Sussex, United Kingdom, 5Indiana University, Indianapolis, IN, 6Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, 7Keck School of Medicine, University of Southern California, Los Angeles, CA, 8The Smith Institute for Urology, The North-Shore Long Island Jewish Health System, New York, NY
12:15 pm - 1:30 pm LUNCH SYMPOSIUM
Meeting Room 552
An Overview of Toviaz and Your Way Plan
Supported by Pfizer
1:30 pm - 3:40 pm CONCURRENT SCIENTIFIC SESSION VII: ENDOUROLOGY/STONES
Ballrooms D/E
Moderators: Brian H. Eisner, M.D.
Stephen F. Schiff, M.D.
1:30 pm 59. Vitamin D Repletion Does Not Increase Urine Calcium In Patients With Vitamin D Deficiency
Brian H. Eisner, M.D., Sherri-Ann Burnett-Bowie, M.D.
Massachusetts General Hospital, Boston, MA
1:40 pm 60. Vitamin D Deficiency May Be Predicted in Patients with Elevated Parathyroid Levels and Normocalcemic Hypercalcuria
Liza Aguiar, M.D., George Haleblian, M.D., Gyan Pareek, M.D.
Brown Medical School, Urology, Providence, RI
1:50 pm 61. Trends in Antibiotic Use After Routine Ureteroscopic Stone Treatment
Michael P. Kurtz, M.D., Brian H. Eisner, M.D.
Massachusetts General Hospital, Boston, MA
2:00 pm 62. Post-Operative Antibiotics Are Not Necessary After Ureteroscopic Stone Treatment
Brian H. Eisner, M.D.1, Michael P. Kurtz, M.D. 1, Boris Gershman, M.D. 1, Olga Arsovska, BA2, Ryan F. Patterson, M.D.2, Ben H. Chew, M.D.2
1Massachusetts General Hospital, Boston, MA, 2University of British Columbia, Vancouver, BC, Canada
2:10 pm 63. Stone Culture is Associated with Urosepsis After Endourological Procedures
Jairam R. Eswara, M.D., Dianne Sacco, M.D.
Massachusetts General Hospital, Cambridge, MA
2:20 pm *64. Office-Based Endourology Using Fluoroscopic Guidance: Clinical Outcomes and Cost-Effectiveness
Boris Gershman, M.D., Brian H. Eisner, M.D., Dianne E. Sacco, M.D.
Massachusetts General Hospital, Boston, MA
2:30 pm 65. Computed Tomography Using Adaptive Statistical Iterative Reconstruction Lowers Radiation Dose Without Compromising Diagnostic Accuracy
Brian H. Eisner, M.D., Avinash Kambadakone, M.D., Dushyant V. Sahani, M.D.
Massachusetts General Hospital, Boston, MA
2:40 pm *66. Resolution of Pain Following Ureteroscopic Treatment Of Small, Non-Obstructing Renal Stones
Ying Jura, M.D., Susan Lahey, M.D., Brian H. Eisner, M.D., Stephen P. Dretler, M.D.
Massachusetts General Hospital, Boston, MA
2:50 pm 67. Diabetic Stone-Formers Excrete Greater Amounts Of Urine Oxalate And Have Lower Urine Ph Than Non-Diabetic Stone-Formers
Brian H. Eisner, M.D. 1, Sima P. Porten, M.D. 2, Seth K. Bechis, M.D. 2, Marshall L. Stoller, M.D. 2
1Massachusetts General Hospital, Boston, MA, 2University of California, San Francisco, San Francisco, CA
3:00 pm 68. Management of Lower Pole Stones: Ureterorenoscopy VS. Tubeless PCNL VS. Shockwave Lithotripsy
Michael S. Lasser, M.D., Sutchin Patel, M.D., Haleblian E. George, M.D., Gyan Pareek, M.D.
Brown University, Providence, RI
3:10 pm - 3:30 pm POINT/COUNTERPOINT
Moderator: Stephen F. Schiff, M.D.
Panelist: Brian H. Eisner, M.D.
Vernon M. Pais, M.D.
3:30 pm - 3:40 pm PEDIATRICS: TAKE HOME MESSAGES FROM SAN FRANCISCO TO PROVIDENCE
Simone Thavaseelan, M.D.
1:30 pm - 3:04 pm CONCURRENT POSTER SESSION III: PROSTATE CANCER
Rotunda
Moderators: David Canes, M.D.
Steven I. Cohen, M.D.
1:30 pm VIEWING
2:00 pm P19. WITHDRAWN
2:08 pm P20. PSA screening in Patients with de novo Metastatic Prostate Cancer
Rian J. Dickstein, M.D., Courtney K. Rowe, B.A., Jessica E. Kreshover, M.D., Richard K. Babayan, M.D., Mark H. Katz, M.D.
Boston University School of Medicine, Boston, MA
2:16 pm P21. Utility of Prostate Size, Patient Age, and Presence of Atypical Small Acinar Proliferation (ASAP) in Prior Biopsy in Selecting Patients for Repeat Biopsy: Results from a Multi-Center Prospective Prostate Biopsy Cohort
Simpa S. Salami, M.D., MPH1, John T. Wei, M.D., MS2, Meredith M. Regan, ScD3, Douglas Scherr, M.D.4, Javed Siddiqui, MS2, Michael Kearney, M.D. 1, Robert Eyre, M.D.1, Gary Kearney, M.D.1, Elizabeth Genega, M.D.1, Mark Rubin, M.D.4, Martin G. Sanda, M.D.1
1Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, 2University of Michigan, Ann Arbor, MI, 3Dana-Farber Cancer Institute, Boston, MA, 4Weill Cornell Medical College, New York, NY
2:24 pm P22. Cost Expenditures for Active Surveillance Versus Active Treatments For Localized Prostate Cancer
Rebecca S. Lavelle, M.D.1, Stephen B. Williams, M.D.1, Jim C. Hu, M.D. 2, Kevin R. Loughlin, M.D.1
1Brigham and Women's Hospital, Division of Urologic Surgery, Boston, MA, 2Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women’s Hospital, Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA
2:32 pm P23. Patients > 70 Years May Be Offered Robot-Assisted Laparoscopic Radical Prostatectomy As A Treatment Option For Localized Prostate Cancer: A Multi-Institutional Experience
Sammy Elsamra, M.D. 1, George Haleblian, M.D, 1, Ihor Sawczuk, M.D. 2, Ravi Munver, M.D. 2, Jennifer K. Yates, MD2, Joseph Renzulli, III, M.D. 1, Gyan Pareek, M.D. 1.
1Brown University, Warren Alpert School of Medicine, Providence, RI, USA, 2Hackensack University Medical Center, Hackensack, NJ, USA.
2:40 pm P24. Has RALRP lead to increased treatment of low risk disease?
Simone Thavaseelan, M.D.1, Michelle Gaudreau, RN, BSN, CCRP2, George Haleblian, M.D1., Gyan Pareek, M.D.1, Renzulli Joseph, Jr., M.D.1
1Brown University, Providence, RI, 2The Miriam Hospital, Providence, RI
2:48 pm P25. A Retrospective Cohort Analysis of Positive Margin Rates in Open VS Robotic-Assisted Laparoscopic Prostatectomy at Brown University
Simone Thavaseelan, M.D. 1, Michelle Gaudreau, RN, BSN, CCRP2, George Haleblian, M.D. 1, Gyan Pareek, M.D. 1, Renzulli Joseph, M.D. 1
1Brown University, Providence, RI, 2The Miriam Hospital, Providence, RI
2:56 pm P26. Accuracy of 1.5-Tesla using 32 channel High Definition Cardiac Coil Magnetic Resonance Imaging for Local Staging of High Risk Prostate Cancer in Comparison to the Partin Tables
Tony Luongo, M.D., Hoon Ji, M.D., Paul Mathew, M.D., Gennaro Carpinito, M.D., Kent Yucel, M.D., Monika Pilichowska, M.D.
Tufts Medical Center, Boston, MA
3:45 pm - 4:30 pm LEADBETTER LECTURE
Ballrooms D/E
The Future of Physicians and Industry in Academics and Research
William D. Steers
University of Virginia, Charlottesville, VA
4:30 pm - 5:00 pm PRESIDENTIAL ADDRESS
Ballroom D/E
“Reproduction in the future: Where are we going?”
Mark Sigman, M.D.
Providence, RI
5:00 pm ADJOURN
6:30 pm – 8:00 pm PRESIDENT’S RECEPTION
RISD Museum
8:00 pm - 11:00 pm PRESIDENT’S BANQUET
Café Nuovo